Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Dudnyk Joins Fishawack Group of Companies; Expands Service Offering and Global Reach

Written by: | admin@medadnews.com | Dated: Wednesday, March 20th, 2019

 

March 20, Horsham, PA — Dudnyk leaders announce the next phase in its evolution as an ever-growing organization by joining The Fishawack Group of Companies. Fishawack is one of the world’s leading independent healthcare communication specialists, with offices in the UK (London, Oxford, Knutsford, Brighton), US (San Diego, Philadelphia), and India.

“By joining forces with Fishawack, Dudnyk will be able to offer clients an even stronger service offering, including expertise in additional verticals like scientific communications and medical education,” says Dudnyk President, Christopher Tobias, PhD. “We are also excited to further expand our global capabilities, both commercially and medically, for our clients who operate on a scale outside of the US.”

Dudnyk offers a specialized focus on rare disease, oncology, and the emergence of breakthrough therapies in molecular medicine. With over 24 commercial launches in the past 12 years, 9 of which were with organizations launching their first commercial product, Dudnyk remains an expert partner in bringing to market life-changing brands for patient populations desperately in need of approved treatments. “Dudnyk’s rare disease, launch, and creative expertise will add valuable depth of experience to our organization,” says Oliver Dennis, CEO of Fishawack. “We’re thrilled to have the Dudnyk team become part of the Fishawack Group.”

“The principals of Fishawack believe in a ‘client-centric’ approach to business, which is very much aligned with what has made Dudnyk unique, successful, and highly sought after in our industry,” says Dudnyk Chief Operations Officer, Rick Sutliff. “We will continue to maintain our dedication to long-lasting client relationships and to producing some of the highest-quality work in our industry.” Tobias, Sutliff, and the Dudnyk senior leadership team will continue to guide the agency in their current roles.

Tobias reports that Dudnyk’s “Unifying Effect” continues to drive success for specialty brands. “Throughout everything we do, there is an underlying belief that uncovering insights into the disconnects between patients and physicians is essential,” state Tobias. “By doing so, we can look for opportunities to create empathy and shared responsibility—which ultimately leads to greater adoption of specialty brands.”

Independently owned for the past 25 years, Dudnyk is an award-winning, full-service healthcare advertising agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They leverage strategic, scientific, and highly creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries. Dudnyk offers a unique culture, fosters individual career growth, and promotes collaboration among all disciplines.

Learn more at dudnyk.com or @DudnykHealth.

 

A Q&A With Dudnyk President Christopher Tobias, PhD

Christopher Tobias

1. Has Dudnyk received offers before? 

Dudnyk has received offers in the past, but our former owner, Ed Dudnyk, did not have an interest in selling. 

2. What made the offer from Fishawack attractive enough to give up independence? 

We are still an independent (Fishawack is a private, independent agency), we are just now part of a larger organization with greater depth with scientific communications and medical communications. They also have established experience throughout Western Europe, which will be a strong benefit to our clients conducting and planning global launches. 

3. When was the offer made? How long did the negotiations take to complete?

The transaction closed on Tuesday, March 19th, and the details of the deal will remain private. 

4, What are Dudnyk’s goals with Fishawack? Are there any proposals for pitches with Fishawack agencies?

We look forward to learning more about all the Fishawack services among their group of companies and understanding how those services could benefit our current and future clients. Equally, the Fishawack companies are also eager to learn more about our service and experiences and how they may be a benefit to their clients today and in the future. 

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom